α-Synuclein structures from fluorescence energy-transfer kinetics: Implications for the role of the protein in Parkinson's disease

Parkinson's disease is associated with the deposition and accumulation of α-synuclein fibrils in the brain. A30P and A53T mutations have been linked to the early-onset familial disease state. Time-resolved tryptophan fluorescence energy-transfer measurements have been used to probe the structures of pseudo-wild-type and mutant (A30P) α-synucleins at physiological pH (7.4), in acidic pH (4.4) solutions, and in the presence of SDS micelles, a membrane mimic. Fluorescent donor–energy acceptor (DA) distance distributions for six different tryptophan/3-nitro-tyrosine pairs reveal the presence of compact, intermediate, and extended conformations of the protein. CD spectra indicate that the protein develops substantial helical structure in the presence of SDS micelles. DA distributions show that micelles induce compaction in the N-terminal region and expansion of the acidic C terminus. In acidic solutions, there is an increased population of collapsed structures in the C-terminal region. Energy-transfer measurements demonstrate that the average DA distances for the W4–Y19 and Y19–W39 pairs are longer in one of the two disease-related mutants (A30P).

[1]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[2]  P J McLean,et al.  Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. , 2000, The Journal of biological chemistry.

[3]  F. Poulsen,et al.  Time-resolved fluorescence studies of the molten globule state of apomyoglobin. , 1996, Journal of molecular biology.

[4]  P. S. St George-Hyslop,et al.  α-Synuclein Membrane Interactions and Lipid Specificity* , 2000, The Journal of Biological Chemistry.

[5]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[6]  Graham R. Fleming,et al.  Subpicosecond fluorescence anisotropy studies of tryptophan in water , 1990 .

[7]  J. Parkinson An Essay on the Shaking Palsy , 2002 .

[8]  R. Perrin,et al.  Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. , 2000, The Journal of biological chemistry.

[9]  P. Lansbury,et al.  Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. , 2002, Biochemistry.

[10]  D. Eliezer,et al.  A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. , 2003, Journal of molecular biology.

[11]  P. V. von Hippel,et al.  Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.

[12]  A. Jonas,et al.  Nanosecond rotational motions of apolipoprotein C-I in solution and in complexes with dimyristoylphosphatidylcholine. , 1982, Biochemistry.

[13]  William H. Press,et al.  Numerical recipes , 1990 .

[14]  R. Scheller,et al.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  A. Jonas,et al.  Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.

[16]  D. Eliezer,et al.  Residual Structure and Dynamics in Parkinson's Disease-associated Mutants of α-Synuclein* , 2001, The Journal of Biological Chemistry.

[17]  Christopher G. Adda,et al.  Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity , 2004 .

[18]  S. L. Mayo,et al.  DREIDING: A generic force field for molecular simulations , 1990 .

[19]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[20]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[21]  David F. Clayton,et al.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.

[22]  Ralf Langen,et al.  Structure of membrane-bound α-synuclein studied by site-directed spin labeling , 2004 .

[23]  Sharon Brunett,et al.  Molecular dynamics for very large systems on massively parallel computers: The MPSim program , 1997 .

[24]  S. P. Moulik,et al.  Thermodynamics of Micelle Formation of Ionic Surfactants: A Critical Assessment for Sodium Dodecyl Sulfate, Cetyl Pyridinium Chloride and Dioctyl Sulfosuccinate (Na Salt) by Microcalorimetric, Conductometric, and Tensiometric Measurements , 2001 .

[25]  P. S. St George-Hyslop,et al.  Defective membrane interactions of familial Parkinson's disease mutant A30P α-synuclein , 2002 .

[26]  Jennifer C. Lee,et al.  Structural features of cytochrome c′ folding intermediates revealed by fluorescence energy-transfer kinetics , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[28]  P. Lansbury,et al.  Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. , 2002, Biochemistry.

[29]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[30]  D. Eliezer,et al.  Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.

[31]  J M Beechem,et al.  Simultaneous determination of intramolecular distance distributions and conformational dynamics by global analysis of energy transfer measurements. , 1989, Biophysical journal.

[32]  J M Beechem,et al.  Time-resolved fluorescence of proteins. , 1985, Annual review of biochemistry.

[33]  L. Brand,et al.  Resonance energy transfer: methods and applications. , 1994, Analytical biochemistry.

[34]  B. Vallee,et al.  [44] Nitration with tetranitromethane. , 1972, Methods in enzymology.

[35]  M. Goedert,et al.  Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson’s Disease Mutation* , 1998, The Journal of Biological Chemistry.

[36]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[37]  W. Press,et al.  Numerical Recipes Example Book (C). , 1989 .

[38]  A. Helenius,et al.  Solubilization of membranes by detergents. , 1975, Biochimica et biophysica acta.

[39]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[40]  Anders Björklund,et al.  Prospects for new restorative and neuroprotective treatments in Parkinson's disease , 1999, Nature.

[41]  G. Withers,et al.  Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons. , 1997, Brain research. Developmental brain research.

[42]  M. Volkenstein,et al.  Statistical mechanics of chain molecules , 1969 .

[43]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[44]  S. Georghiou,et al.  Melittin-phospholipid interaction studied by employing the single tryptophan residue as an intrinsic fluorescent probe. , 1982, Biochimica et biophysica acta.

[45]  A. Schober,et al.  Genes, proteins, and neurotoxins involved in Parkinson’s disease , 2004, Progress in Neurobiology.

[46]  David F. Clayton,et al.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.

[47]  G. Bignami From entropy to Duino , 1999, Nature.

[48]  V. Uversky,et al.  Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.

[49]  H. Scheraga,et al.  Distributions of intramolecular distances in the reduced and denatured states of bovine pancreatic ribonuclease A. Folding initiation structures in the C-terminal portions of the reduced protein. , 2001, Biochemistry.

[50]  R. Anthony Crowther,et al.  Synthetic filaments assembled from C‐terminally truncated α‐synuclein , 1998 .

[51]  D. Marsh,et al.  Alpha-synuclein association with phosphatidylglycerol probed by lipid spin labels. , 2003, Biochemistry.

[52]  E. Zamrini,et al.  Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. , 1997, The American journal of pathology.

[53]  L. Thal,et al.  Expression Pattern of Synucleins (Non‐Aβ Component of Alzheimer's Disease Amyloid Precursor Protein/α‐Synuclein) During Murine Brain Development , 1998 .

[54]  M. Citron,et al.  Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.

[55]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.

[56]  W. Hill,et al.  Contribution of somal Lewy bodies to neuronal death , 1997, Brain Research.

[57]  T. Dawson New Animal Models for Parkinson's Disease , 2000, Cell.

[58]  J. Lakowicz Principles of fluorescence spectroscopy , 1983 .

[59]  Julia G. Lyubovitsky,et al.  Structural features of the cytochrome C molten globule revealed by fluorescence energy transfer kinetics. , 2002, Journal of the American Chemical Society.

[60]  P. Lansbury,et al.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.

[61]  Jie Li,et al.  The Association of α-Synuclein with Membranes Affects Bilayer Structure, Stability, and Fibril Formation* , 2003, Journal of Biological Chemistry.

[62]  Reinhard Jahn,et al.  A Broken α-Helix in Folded α-Synuclein* , 2003, The Journal of Biological Chemistry.

[63]  M. Beal,et al.  Experimental models of Parkinson's disease , 2001, Nature Reviews Neuroscience.

[64]  P. Lansbury,et al.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.